Home · Guides · Before you start
Before you startBirth control, PMOS and tirzepatide: the four weeks that need a plan
Many women with PMOS take the pill for their cycles. Tirzepatide changes how well it is absorbed at predictable moments. Here is the plan.
For a lot of women with PCOS (PMOS), the combined contraceptive pill is part of everyday care: it regulates cycles, eases androgen symptoms such as acne and unwanted hair, and prevents pregnancy. If you are now considering tirzepatide, the medication most GLP-1 telehealth programs prescribe, there is one specific interaction to plan for before your first dose.
What the label says
Tirzepatide slows how fast the stomach empties. That effect is strongest just after you start and just after each dose increase, and during those windows the body can absorb less of a medication taken by mouth. So the FDA label for tirzepatide (Zepbound and Mounjaro) advises that anyone using an oral hormonal contraceptive switch to a non-oral method, or add a barrier method such as condoms, for four weeks after starting and for four weeks after each dose increase.
Hormonal methods that are not swallowed, such as an IUD, implant, patch, ring or injection, are not expected to be affected in the same way.
Why this matters more with PMOS
Two reasons. First, dose increases with tirzepatide usually come every four weeks or so during titration, which means the “four weeks after” windows can run back to back for several months. It is less a single month to get through and more a phase of treatment to plan for.
Second, PMOS itself can make ovulation irregular, and some women have come to assume pregnancy is unlikely for them. As weight and insulin sensitivity improve, cycles can become more regular for some women, which can mean ovulation returns sooner than expected. That is a reason to take contraception seriously during treatment, not a reason to expect a change in fertility, and nothing here is a fertility treatment or a promise of one.
A titration schedule is also a contraception schedule. Put them on the same calendar.
If you are trying to conceive, or might
GLP-1 medications are not used in pregnancy. The tirzepatide label advises stopping when pregnancy is recognised, and semaglutide’s label advises stopping at least two months before a planned pregnancy. If pregnancy is part of your plans, say so at your first appointment, so the timeline can be set deliberately rather than discovered.
What to ask before your first dose
Bring these to your GLP-1 provider
- “I take an oral contraceptive for my PMOS. What do you recommend during the four weeks after I start and after each increase?”
- “What is my titration schedule, so I can see when those windows fall?”
- “If the pill is also managing my cycles and androgen symptoms, should I talk to the clinician who prescribed it about a non-oral option?”
- “What should I tell you if my cycle changes?”
A provider fluent in PMOS will raise this before you do. That is the second of the Root Eight, PMOS and androgen fluency, and the fourth, a dose made for your body, working together. Our full comparison shows how each of the thirteen providers scores on both.
Nothing here suggests stopping or changing your contraceptive on your own. Any change belongs in a conversation with a licensed clinician who knows your history. GLP-1 medications are not FDA-approved to treat PCOS (PMOS), and compounded tirzepatide is not FDA-approved or reviewed by the FDA for safety or efficacy.